These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11015289)

  • 1. RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.
    Barrett TD; MacLeod BA; Walker MJ
    Br J Pharmacol; 2000 Oct; 131(3):405-14. PubMed ID: 11015289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.
    Sarraf G; Barrett TD; Walker MJ
    Br J Pharmacol; 2003 Aug; 139(8):1389-98. PubMed ID: 12922925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias.
    Barrett TD; Walker MJ
    J Mol Cell Cardiol; 1998 May; 30(5):999-1008. PubMed ID: 9618240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Bril A; Landais L; Gout B
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias.
    Barrett TD; Hayes ES; Walker MJ
    Eur J Pharmacol; 1995 Oct; 285(3):229-38. PubMed ID: 8575508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tedisamil: master switch of nature?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Jan; 10(1):129-38. PubMed ID: 11116286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias.
    Xu R; Abraham S; McLarnon JG; Walker MJ
    Life Sci; 1997; 61(3):237-48. PubMed ID: 9217283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart.
    Fazekas T; Scherlag BJ; Carlsson L; Mabo P; Patterson E; Berlin KD; Lazzara R
    Acta Physiol Hung; 1995; 83(1):13-30. PubMed ID: 7660832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lignocaine on dispersion of repolarisation and refractoriness in a working rabbit heart model of regional myocardial ischaemia.
    Wolk R; Cobbe SM; Hicks MN; Kane KA
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):253-61. PubMed ID: 9475267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.